Science Advances · 2024 · 19 citations · 40 references
Life SciencesMolecular BiologyOncologyChromatin BiologyDna RepairMolecular OncologyApoptosis In CancerApoptosis ResistanceChromatinDna DamageDna Damage SignalingDna Damage-induced ApoptosisDna Damage Response PathwaysDna Damage Response SignalingDna Damage ResponsesDna Damage-induced Cell DeathParp InhibitionParp Inhibitor ResistanceParp Inhibitor SensitivityReplicative Stress
PARP inhibitors (PARPi) represent a game-changing treatment for patients with ovarian cancer with tumors deficient for the homologous recombination (HR) pathway treated with platinum (Pt)-based therapy. PARPi exert their cytotoxic effect by both trapping PARP1 on the damaged DNA and by restraining its enzymatic activity (PARylation). How PARP1 is recruited and trapped at the DNA damage sites and how resistance to PARPi could be overcome are still matters of investigation. Here, we described PARP1 as a substrate of the deubiquitinase USP1. At molecular level, USP1 binds PARP1 to remove its K63-linked polyubiquitination and controls PARP1 chromatin trapping and PARylation activity, regulating sensitivity to PARPi. In both Pt/PARPi-sensitive and -resistant cells, USP1/PARP1 combined blockade enhances replicative stress, DNA damage, and cell death. Our work dissected the biological interaction between USP1 and PARP1 and recommended this axis as a promising and powerful therapeutic choice for not only sensitive but also chemoresistant patients with ovarian cancer irrespective of their HR status.
40
Highly accurate protein structure prediction with AlphaFold
John Jumper, Alexander Pritzel, Tim Green et al. · Nature · 2021 · 45.2K citations · Full text
Protein complex prediction with AlphaFold-Multimer
M. E. O’Neill, Alexander Pritzel, Andrew Senior et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 4.1K citations
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Tools for integrated sequence-structure analysis with UCSF Chimera
Elaine C. Meng, Eric F. Pettersen, Gregory S. Couch et al. · BMC Bioinformatics · 2006 · 763 citations · Full text